Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffrey Moscow
Jeffrey Moscow
Internal medicine
Medicine
Oncology
Anesthesia
Gastroenterology
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Osimertinib (Osi) plus necitumumab (Neci) in EGFR-mutant NSCLC: An ETCTN California cancer consortium phase I study.
2019
Journal of Clinical Oncology
Jonathan W. Riess
Susan Groshen
Karen L. Reckamp
Heather A. Wakelee
Geoffrey R. Oxnard
Sukhmani K. Padda
Marianna Koczywas
Zofia Piotrowska
Lynette M. Sholl
Cloud P. Paweletz
Christie J. Lau
Jill M. Kolesar
Philip C. Mack
Jeffrey Moscow
Pasi A. Jänne
Primo N. Lara
Edward M. Newman
David R. Gandara
Show All
Source
Cite
Save
Citations (4)
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)
2016
Investigational New Drugs
Joanne Chiu
Sebastien J. Hotte
Christian Kollmannsberger
Daniel John Renouf
David W. Cescon
David W. Hedley
Sue Chow
Jeffrey Moscow
Zhuo Chen
Meghan Perry
Ivan Diaz-Padilla
David Sp Tan
Hal W. Hirte
Elaine McWhirter
Helen Chen
Lillian L. Siu
Philippe L. Bedard
Show All
Source
Cite
Save
Citations (12)
1